Christopher G. England
- Molecular Biology top 10%
- Biomedical Engineering top 2%
- Radiology, Nuclear Medicine and Imaging top 2%
- Oncology top 5%
- Biomaterials top 2%
- Co-authors
- Weibo CaiEmily B. EhlerdingHaiming LuoDawei JiangReinier HernandezHaiyan SunTodd E. BarnhartShreya Goel
- Topics
- Nanoparticle-Based Drug Delivery (12 papers)Nanoplatforms for cancer theranostics (10 papers)Monoclonal and Polyclonal Antibodies Research (9 papers)
- Journals
- Proceedings of the National Academy of SciencesAngewandte Chemie International EditionACS Nano
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Christopher G. England
50 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Molecular Biology 1.3k
- Biomedical Engineering 1.2k
- Radiology, Nuclear Medicine and Imaging 762
- Oncology 707
- Biomaterials 527
Countries citing papers authored by Christopher G. England
This map shows the geographic impact of Christopher G. England's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher G. England with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher G. England more than expected).
Fields of papers citing papers by Christopher G. England
This network shows the impact of papers produced by Christopher G. England. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher G. England. The network helps show where Christopher G. England may publish in the future.
Co-authorship network of co-authors of Christopher G. England
This figure shows the co-authorship network connecting the top 25 collaborators of Christopher G. England. A scholar is included among the top collaborators of Christopher G. England based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher G. England. Christopher G. England is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 30 | |
| 2 | 37 | |
| 3 | 30 | |
| 4 | 17 | |
| 5 | 30 | |
| 6 | 25 | |
| 7 | 56 | |
| 8 | 58 | |
| 9 | 160 | |
| 10 | 156 | |
| 11 | 19 | |
| 12 | 151 | |
| 13 | 61 | |
| 14 | 61 | |
| 15 | 32 | |
| 16 | 28 | |
| 17 | 33 | |
| 18 | 12 | |
| 19 | 36 | |
| 20 | 30 |
About Christopher G. England
Christopher G. England is a scholar working on Structural Biology, Immunology and Allergy and Biomaterials, having authored 50 papers that have together received 3.3k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (12 papers), Nanoplatforms for cancer theranostics (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). The work is most often cited by research in Biomaterials (527 citations), Radiology, Nuclear Medicine and Imaging (762 citations) and Biomedical Engineering (1.2k citations). Christopher G. England has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Weibo Cai, Emily B. Ehlerding, Haiming Luo, Dawei Jiang, Reinier Hernandez, Haiyan Sun, Todd E. Barnhart, Shreya Goel, Feng Chen and Stephen A. Graves. Their work appears in journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.